Novavax.
company in Gaithersburg, Maryland
- Reports this week
- 0
- Active events
- 0
- Connections
- 60
What's happening
One to three months ago
-
AstraZeneca and Novavax are pursuing technology transfer to enable local vaccine production.Some support1 report
-
On August 28, 2026, the FDA approved Moderna's mNEXSPIKE vaccine and gave the green light to Novavax's Nuvaxovid vaccine. Separately, ProFound Therapeutics was formed by Flagship Pioneering.Some support1 report
-
Novavax, Nvidia, Biogen, and Amgen are involved in developments regarding specialized infrastructure and their shared status as peers in the therapeutics segment.Some support2 reports
-
Taiwan is utilizing Moderna and Novavax doses for COVID-19 vaccination.Some support1 report
-
Novavax is involved in managing specific vaccine stock for high-risk groups under the oversight of a governmental public health body.Some support2 reports
Gone quiet
No new reports in 90+ days-
Market performance comparison in the vaccine sector was noted, alongside an upcoming August 5th FDA decision on a flu candidate.Some support1 report
-
Young's career timeline includes appointments at TechImmune, service on the Novavax board, and academic/professional ties to GlaxoSmithKline in NYC and Houston.Some support1 report
-
AI stocks benefit from Trump-era tariffs, while Novavax released data showing its flu vaccine outperformed FLUZONE-HD.Some support2 reports
-
Novavax and Canopy Growth are facing lagging stock performance while operating in Canada and Germany.Some support1 report
-
Novavax is a vaccine maker operating in the medical sector.Some support1 report
-
Novavax's stock performance on July 31, 2025, was noted against the backdrop of the broader market's losses, showing both lags and outperformance.Some support3 reports
-
FDA approved Novavax's Nuvaxovid BLA, leading to Sanofi receiving a milestone payment and taking over U.S. commercial leadership.Well supported9 reports1 development inside
-
Novavax and Sanofi announced a partnership to facilitate vaccine access.Well supported3 reports
-
Incepta Pharmaceuticals and Novavax were mentioned in a report on August 13, 2025, noting that industry performance influences stock trends.Some support1 report
-
Novavax faces an uncertain outlook regarding its vaccine programs, as reported by Bank of America.Some support1 report
-
FDA approved updated COVID-19 vaccines on August 29, 2025, involving companies like Novavax, Moderna, and Pfizer.Well supported6 reports1 development inside
-
Novavax started using LinkedIn on September 3, 2025, for company information.Some support2 reports
-
Novavax received a milestone payment following regulatory approval in Japan.Some support1 report
-
Jefferies reaffirmed a buy rating on Novavax shares, amidst discussions regarding potential updates to COVID-19 vaccines and FDA considerations.Some support4 reports
-
Novavax stock is trading on the Nasdaq electronic stock exchange, with company news and ratings being aggregated by MarketBeat.Some support6 reports
No events began in the chosen period. Widen it, or reset.
Around Novavax this week
News at the entities that move Novavax most-
FDA StructuralNeurogene Inc. developed a gene therapy for Rett syndrome and received FDA agreement for a registrational trial design.Moves Novavax
-
Food and Drug Administration StructuralFDA conducted a search operation in Pune on January 1, 2026.Moves Novavax
-
Jefferies Financial Group Mentioned togetherGE Vernova received a 'buy' rating and target price raise from Jefferies, alongside required SEC filings on May 27, 2026.Moves Novavax
-
Sanofi OperationalSanofi and Recursion Pharmaceuticals formed a partnership to develop AI-enabled therapies.Moves Novavax
-
Moderna OperationalModerna and BioNTech are recognized as leaders in the personalized cancer vaccine space.Moves Novavax
-
Nasdaq StructuralA Vertex employee won an Info-Tech award, the company is listed on Nasdaq, and Sarah Vlasic leads Leadership Circles at the University of Colorado Boulder.Moves Novavax
Connections
The 20 strongest of 60, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Sanofi Structural
Novavax licensed its vaccine technology to Sanofi, which subsequently took over commercialization efforts and provided milestone payments.
-
FDA Structural
The FDA formally evaluates, regulates, and grants market approval for Novavax's vaccine products.
-
Moderna Operational
Novavax and Moderna are direct competitors in the vaccine market, vying for market share and influencing each other's stock performance.
-
Pfizer Operational
Novavax and Pfizer are direct competitors offering alternative products in the market.
-
Takeda Structural
Takeda provides financial support to Novavax through royalty payments, boosting its market outlook.
-
Nasdaq Structural
Novavax is a publicly traded company that lists its shares and reports earnings on the Nasdaq stock exchange.
-
Sanofi Operational
An active commercial partnership exists where Sanofi's operations and revenue streams support Novavax's market momentum and product commercialization.
-
Food and Drug Administration Structural
The FDA regulates Novavax, granting market access through approvals and imposing delays.
Show all 20 connections
-
Jefferies Financial Group Mentioned together
Jefferies Financial Group provides financial ratings and research notes on Novavax.
-
Biogen Operational
The evidence indicates that both companies are direct competitors operating as peers within the therapeutics segment.
-
Centers for Disease Control Operational
Novavax utilizes vaccine stock managed by the Centers for Disease Control for high-risk groups.
-
LinkedIn Operational
Novavax actively uses LinkedIn as a platform to gather company and general information.
-
MarketBeat Mentioned together
MarketBeat aggregates and reports financial data, news, and stock ratings for Novavax.
-
TD Cowen Mentioned together
A is a financial services firm whose business includes providing market analysis and ratings for companies like B.
-
Incepta Pharmaceuticals Mentioned together
Both Incepta Pharmaceuticals and Novavax are categorized within the medical sector.
-
AstraZeneca Operational
Both Novavax and AstraZeneca are actively pursuing vaccine technology transfer.
-
Nvidia Shared context
The two companies operate within the same high-tech ecosystem, where Nvidia's products require specialized infrastructure.
-
Amgen Operational
Novavax and Amgen are identified as competitors operating within the therapeutics segment.
-
Gaithersburg Shared context
Novavax is based in Gaithersburg, Maryland.
-
Ibb Shared context
No evidence was found linking Novavax and Ibb in the provided timeline.
History
Events by the month they beganSeptember 2026
1 eventAugust 2026
2 events- On August 28, 2026, the FDA approved Moderna's mNEXSPIKE vaccine and gave the green light to Novavax's Nuvaxovid vaccine. Separately, ProFound Therapeutics was formed by Flagship Pioneering.
- Novavax, Nvidia, Biogen, and Amgen are involved in developments regarding specialized infrastructure and their shared status as peers in the therapeutics segment.
July 2026
2 eventsShow 1 earlier month
June 2026
15 events- Market performance comparison in the vaccine sector was noted, alongside an upcoming August 5th FDA decision on a flu candidate.
- Young's career timeline includes appointments at TechImmune, service on the Novavax board, and academic/professional ties to GlaxoSmithKline in NYC and Houston.
- AI stocks benefit from Trump-era tariffs, while Novavax released data showing its flu vaccine outperformed FLUZONE-HD.
- Novavax and Canopy Growth are facing lagging stock performance while operating in Canada and Germany.
- Novavax is a vaccine maker operating in the medical sector.
- Novavax's stock performance on July 31, 2025, was noted against the backdrop of the broader market's losses, showing both lags and outperformance.
- FDA approved Novavax's Nuvaxovid BLA, leading to Sanofi receiving a milestone payment and taking over U.S. commercial leadership.
- Novavax and Sanofi announced a partnership to facilitate vaccine access.
- Incepta Pharmaceuticals and Novavax were mentioned in a report on August 13, 2025, noting that industry performance influences stock trends.
- Novavax faces an uncertain outlook regarding its vaccine programs, as reported by Bank of America.
- FDA approved updated COVID-19 vaccines on August 29, 2025, involving companies like Novavax, Moderna, and Pfizer.
- Novavax started using LinkedIn on September 3, 2025, for company information.
- Novavax received a milestone payment following regulatory approval in Japan.
- Jefferies reaffirmed a buy rating on Novavax shares, amidst discussions regarding potential updates to COVID-19 vaccines and FDA considerations.
- Novavax stock is trading on the Nasdaq electronic stock exchange, with company news and ratings being aggregated by MarketBeat.